Wendell M. Starke

Founded in 1994, Global Index Advisors, Inc. (GIA), a Delaware corporation, is a registered investment advisor located in Marietta, Georgia. GIA is the successor entity of Global Index Advisors, Inc. (GIAG), a Georgia corporation. On May 19, 2014, GIA, a wholly-owned subsidiary of Legal & General Investment Management America, Inc. (LGIMA), acquired substantially all of the assets of GIAG. In a subsequent intra-company reorganization, the shares of GIA and the shares of LGIMA were purchased by a recently-formed and affiliated holding company, Legal & General Investment Management United States (Holdings), Inc., which is the wholly-owned subsidiary of Legal & General Investment Management (Holdings) Ltd., itself a subsidiary of Legal & General Group Plc (LON: LGEN). GIA acts as a sub-advisor to a series of registered Target Date mutual funds and to two series of bank collective Target Date funds. The firm provides separate account management services to corporations, foundations and individuals on a discretionary basis. They also license their investment methodology to other Registered Investment Advisors.

Amvescap Plc (Georgia) provides investment management services. The company operates principally through the AIM, INVESCO, and Atlantic Trust brands. The company is headquartered in Atlanta, GA.

Invesco, Inc. provides investment management services. The company is headquartered in Nashville, TN.

Father Flanagan's Boys' Home provides child care and treatments services. It offers services for children’s emotional and behavioral issues. The company was founded by Edward J. Flanagan in 1917 and is headquartered in Boys Town, NE.

Willis Investment Counsel, Inc. (WIC) is an independent, SEC-registered investment advisor headquartered in Gainesville, Georgia. The firm was founded in 1979 by Robert T. Willis, Jr. WIC manages assets for a wide array of clients such as individuals, corporations, captive insurance companies, foundations, endowments, and pension/401(k) plans.

CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD.